Preclinical Imaging Core Lab for Medical Devices
Why Companies Choose NAMSA.
Medical Device Preclinical Projects Last Year
Fully Equipped ORs and Cath Labs in US and Europe
Labs in US and Europe Offering Preclinical Services
Therapeutic Areas in Which NAMSA Has Experience
End-to-End Preclinical Imaging Core Lab Expertise
NAMSA delivers end‑to‑end preclinical imaging Core Lab services that support medical device development from early feasibility through pivotal‑enabling studies. Our integrated approach ensures imaging data is scientifically robust, clinically relevant, and aligned with global regulatory expectations. We support the full imaging lifecycle, including:
- Study design
- Model selection
- Image acquisition
- Data analysis
- Data interpretation
- Reporting
Therapeutic Area–Specific Imaging Experience
NAMSA brings deep therapeutic area–specific imaging expertise to preclinical medical device development, ensuring imaging strategies are tailored to the anatomy, pathology, and clinical use of each device. Our experience spans a wide range of indications, allowing us to design imaging endpoints that are both scientifically rigorous and clinically meaningful.
Key therapeutic areas supported include:
- Coronary, Cerebral, and Peripheral Vascular
- Cardiology
- Neurology
- Orthopedics & Musculoskeletal
- Oncology
Advanced Imaging Modalities
NAMSA provides access to a comprehensive portfolio of advanced preclinical imaging modalities, enabling detailed anatomical, functional, and longitudinal assessment of medical devices. Imaging approaches are selected based on study objectives, target anatomy, and intended regulatory use of the data.
Our modalities support non‑destructive, repeatable evaluation over time, allowing early insight into device behavior, tissue interaction, and biological response. Standardized acquisition and analysis protocols ensure repeatability, consistency, and cross‑study comparability.
Available preclinical imaging modalities include:
- Cone-beam CT (CB-CT) (Fluoroscopy) and 128-Slice CT
- Micro‑Computed Tomography (micro‑CT)
- Magnetic Resonance Imaging (MRI)
- Ultrasound Imaging
- Optical Imaging
- Fluoroscopy
- X-Ray
- Angiography
- Intravascular Imaging (e.g., IVUS, OCT)
Learn about our special preclinical program for MedTech startups
A Trusted Partner for Preclinical Imaging Core Lab Services
NAMSA combines deep preclinical expertise with advanced imaging capabilities to support medical device innovation at every stage of development. Sponsors work with a single, experienced partner that understands how imaging data fits into the bigger picture—supporting device safety, performance evaluation, and translational relevance. Our teams apply scientific rigor, standardized methodologies, and cross‑functional insight to ensure imaging results are clear, consistent, and decision‑ready.
What sets NAMSA’s Preclinical Imaging Core Lab approach apart:
- Imaging expertise embedded within a comprehensive preclinical and regulatory ecosystem
- Strong focus on data quality, reproducibility, and translational relevance
- Multidisciplinary scientific and clinical interpretation of imaging results
- Proven experience supporting complex, high‑risk medical device programs
Take the Next Step
Want to learn more about our imaging capabilities for preclinical research?
Meet Our Preclinical Experts
Explore the depth of our team’s expertise in preclinical imaging core lab services in support of clinical research.
-
Michael A. Jorgenson, BS
Principal InterventionalistView Bio -
Tyler LaMont
Senior InterventionalistView Bio -
Jeff Geschwind, MD
Medical Director–Oncology, Image-Guided Therapy, and Imaging Core LabView Bio -
Corey Leet
Director, Regional Preclinical and In-Vivo Biocompatibility OperationsView Bio -
Isabelle Truyers, DVM, DipECBHM
Director of Laboratory Operations DiestView Bio
Related Services That May Interest You
GLP Preclinical Studies
Non-GLP Studies